Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
1. 系统已在2026-04-29 16:10:37对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1470-2045(25)00643-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525006436
其他信息:
出版社: Elsevier BV
作者: Liang Zhang; Xiqin Zhang; Lin Wu; Wenqun Xing; Chunling Liu; Peng Zhang; Kai Chen; Jianhua Shi; Shidong Xu; Xiaodong Zhang; Xiaorong Dong; Haohui Fang; Xinmin Yu; Yang Gao; Gaofeng Li; Zhenming Chen; Shaonan Fan; Xiaoqing Zhang; Ying Cheng

